Insider Buying: Walgreens Boots Alliance Inc (WBA) Director Acquires $1,340,000.00 in Stock

Walgreens Boots Alliance Inc (NASDAQ:WBA) Director John Anthony Lederer acquired 20,000 shares of the firm’s stock in a transaction dated Thursday, October 26th. The shares were purchased at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the completion of the acquisition, the director now directly owns 50,000 shares in the company, valued at $3,350,000. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 EPS for the quarter, beating the Zacks’ consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The company had revenue of $30.15 billion for the quarter, compared to the consensus estimate of $29.93 billion. During the same quarter in the previous year, the business earned $1.07 earnings per share. The company’s revenue for the quarter was up 5.3% on a year-over-year basis.

Walgreens Boots Alliance announced that its board has approved a share buyback plan on Wednesday, October 25th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the pharmacy operator to buy shares of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s leadership believes its shares are undervalued.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, November 10th. This represents a $1.60 dividend on an annualized basis and a yield of 2.41%. Walgreens Boots Alliance’s dividend payout ratio is currently 42.33%.

ILLEGAL ACTIVITY NOTICE: “Insider Buying: Walgreens Boots Alliance Inc (WBA) Director Acquires $1,340,000.00 in Stock” was reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this piece on another domain, it was copied illegally and republished in violation of United States & international copyright & trademark law. The correct version of this piece can be accessed at https://sportsperspectives.com/2017/11/02/insider-buying-walgreens-boots-alliance-inc-wba-director-acquires-1340000-00-in-stock.html.

Large investors have recently bought and sold shares of the business. IBM Retirement Fund raised its position in Walgreens Boots Alliance by 88.1% in the second quarter. IBM Retirement Fund now owns 22,903 shares of the pharmacy operator’s stock valued at $2,004,000 after purchasing an additional 10,729 shares during the period. Andra AP fonden raised its position in Walgreens Boots Alliance by 35.3% in the second quarter. Andra AP fonden now owns 58,300 shares of the pharmacy operator’s stock valued at $4,565,000 after purchasing an additional 15,200 shares during the period. Schwab Charles Investment Management Inc. raised its position in Walgreens Boots Alliance by 5.4% in the second quarter. Schwab Charles Investment Management Inc. now owns 3,019,739 shares of the pharmacy operator’s stock valued at $236,476,000 after purchasing an additional 154,995 shares during the period. Birinyi Associates Inc. raised its position in Walgreens Boots Alliance by 9.0% in the second quarter. Birinyi Associates Inc. now owns 9,100 shares of the pharmacy operator’s stock valued at $713,000 after purchasing an additional 750 shares during the period. Finally, Montecito Bank & Trust raised its position in Walgreens Boots Alliance by 3.6% in the second quarter. Montecito Bank & Trust now owns 6,661 shares of the pharmacy operator’s stock valued at $522,000 after purchasing an additional 230 shares during the period. Institutional investors own 60.24% of the company’s stock.

WBA has been the topic of several recent research reports. Pivotal Research decreased their price objective on Walgreens Boots Alliance from $85.00 to $73.00 and set a “hold” rating on the stock in a report on Tuesday, October 24th. Loop Capital initiated coverage on Walgreens Boots Alliance in a report on Thursday, August 24th. They set a “buy” rating and a $95.00 price objective on the stock. Needham & Company LLC reaffirmed a “buy” rating and set a $94.00 price objective on shares of Walgreens Boots Alliance in a report on Thursday, October 12th. BidaskClub cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Tuesday, September 12th. Finally, Royal Bank Of Canada reaffirmed a “buy” rating and set a $88.00 price objective on shares of Walgreens Boots Alliance in a report on Wednesday, October 25th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have assigned a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $88.00.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Insider Buying and Selling by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply